GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Stock Based Compensation

NKGen Biotech (NKGen Biotech) Stock Based Compensation : $2.05 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Stock Based Compensation?

NKGen Biotech's Stock Based Compensation for the three months ended in Mar. 2024 was $1.12 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was $2.05 Mil.


NKGen Biotech Stock Based Compensation Historical Data

The historical data trend for NKGen Biotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Stock Based Compensation Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Stock Based Compensation
0.09 0.07 4.14

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial 0.02 1.26 - 0.93 1.12

NKGen Biotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.05 Mil.


NKGen Biotech Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.